Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model

  • Takuya Fujimoto
  • , Tooru Andoh
  • , Tamotsu Sudo
  • , Ikuo Fujita
  • , Hiroshi Moritake
  • , Tohru Sugimoto
  • , Toshiko Sakuma
  • , Toshihiro Akisue
  • , Shinji Kawabata
  • , Mitsunori Kirihata
  • , Minoru Suzuki
  • , Yoshinori Sakurai
  • , Koji Ono
  • , Yoshinobu Fukumori
  • , Masahiro Kurosaka
  • , Hideki Ichikawa

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

Clear cell sarcoma of tendons and aponeuroses (CCS) is a rare malignant tumor with no effective treatment. This study demonstrates the efficacy of BNCT with the use of human CCS-bearing nude mice. Groups A and C were administered saline, and groups B and D were injected with p-borono- l-phenylalanine-fructose complex. Groups C and D were then irradiated with thermal neutrons. The tumors in only group D disappeared, demonstrating that BNCT is a potentially new option for the treatment of human CCS.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalApplied Radiation and Isotopes
Volume73
DOIs
Publication statusPublished - 03-2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiation

Fingerprint

Dive into the research topics of 'Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model'. Together they form a unique fingerprint.

Cite this